Oxford Finance, Silicon Valley Provide $55MM Halozyme Refi
Halozyme Therapeutics entered into an agreement with Oxford Finance and Silicon Valley Bank to refinance its existing senior secured loan facility.
June 9, 2016
Holozyme Therapeutics | Oxford Finance | Silicon Valley Bank
ABF Journal